Special Issue on Clinical Immunology

Submission Deadline: Apr. 15, 2020

Please click the link to know more about Manuscript Preparation: http://www.clinexpmed.org/submission

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Jose Lucas Rocha
      Department of Basic and Applied Immunology, Faculty of Medicine of Ribeirão Preto - USP, Ribeirao Preto, Brazil
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Rafael Pontes
      Department of Basic and Applied Immunology, Faculty of Medicine of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Cícero Jose Almeida
      Department of Biosciences and Biotechnology, Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Rafaela Felício
      Department of Biosciences and Biotechnology, Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Luiz Felipe Araujo
      Department of Basic and Applied Immunology, Faculty of Medicine of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Murillo Duarte
      Department of Basic and Applied Immunology, Faculty of Medicine of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Nadia Noronha
      Department of Biosciences and Biotechnology, Faculty of Pharmaceutical Sciences of Ribeirão Preto - USP, Ribeirao Preto, Brazil
    • Keila Zaniboni Siqueira Batista
      Universidade Regional de Blumenau, FURB, Blumenau, SC, Brazil
  • Introduction

    From a clinical perspective, many diseases and conditions are obviously linked to the inadequate functioning of the immune system. Insufficient immune responses may produce uncontrollable acute or chronic infections. However, overt manifest responses of the immune system to infections, such as those seen in cases of septic shock or acute respiratory distress syndrome (ARDS), can also have fatal consequences. There are self-injurious responses to innocuous foreign materials or autoantigens that trigger allergies and autoimmunity problems, respectively. In addition to the classic role played in these infectious and inflammatory diseases, the immune system also plays an important role in the surveillance and control of solid tumors, hematologic malignancies, cardiovascular disease, sickle cell anemia, obesity-related health complications, and intestinal disease, for example. Consequently, knowledge of the role played by immunity in disease processes is becoming increasingly indispensable in all aspects of clinical practice. In this Special Issue we evaluate the special components of the immune system in view of the impact that immune responses have on the pathogenesis of several diseases, the targets for clinical treatments, as therapeutic agents used to control autoimmunity, either through the macanistic comparison of old and new drugs, or cell-based therapies that boost or modulate the immune system. Therefore, the objectives of this Special Issue are to check the subjects covered by Clinical Immunology, such as studies involving cases of autoimmune diseases and hematopoietic stem cell transplantation, mesenchymal stromal cells in clinical routine or in animal models, studies involving production and testing of vaccines, studies relating the manufacture of recombinant antibodies against viral infections, studies addressing the influence of commensal microbiota on immunity and tolerance, studies addressing the hormonal influence on the development or control of inflammation, preclinical studies involving models diabetes mellitus (type I preferably), psoriasis, multiple and systemic sclerosis, clinical cases and laboratory components involving inflammation in sickle cell anemia, chronic intestinal inflammation studies, and chronic skin wounds studies able to new/alternative therapeutic possibilities, not forgetting CAR T cells as tool against specific cancers.
    Aims and Scope:
    1. Mesenchymal Stromal Cells
    2. Immunomodulation
    3. Inflammatory diseases
    4. Cell Therapy
    5. Antibody Therapy
    6. Autoimmune Diseases

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.clinexpmed.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.